Raised prolactin levels or Hyperprolactinemia

Authored by Partha Kar, published on 2026-05-28 07:11:03.0

The algorithm is broadly aligned with contemporary hyperprolactinaemia care: confirm true elevation, exclude physiologic/secondary/drug causes (including macroprolactin), proceed to pituitary MRI when persistent, and treat symptomatic prolactinomas primarily with dopamine agonists (cabergoline preferred). It appropriately places transsphenoidal surgery as second-line for intolerance/resistance or urgent complications and includes reasonable follow-up and consideration of dopamine-agonist withdrawal after sustained remission. Overall, it reflects major Endocrine Society/Pituitary Society recommendations, though some thresholds and follow-up intervals may vary by guideline and local practice.

  1. CONFIRM DIAGNOSIS
    • Repeat prolactin (fasting, low stress) • Mild ↑ = <2–3× ULN • Very high (>5000 mIU/L / >200 ng/mL) → Prolactinoma likely
    • Persistent elevation → Pituitary MRI
      • CAUSES AFTER MRI
        No tumor → Stalk effect / secondary cause Prolactinoma: Micro (<10 mm) Macro (>10 mm)
        • TREAT OR OBSERVE?
          Asymptomatic → Observe (esp. macroprolactin) Symptomatic (amenorrhea, infertility, ED, galactorrhea) → Treat
          • FIRST-LINE TREATMENT
            Dopamine Agonists (↓ prolactin, ↓ tumor size) Cabergoline (preferred) Bromocriptine (pregnancy preferred) MACROPROLACTINOMA KEY POINT • Medical therapy = FIRST LINE (even with visual symptoms)• Rapid shrinkage expected
            • WHEN TO CONSIDER SURGERY
              • Drug failure / intolerance • Persistent visual compromise • Pituitary apoplexy → Transsphenoidal surgery
              • FOLLOW-UP
                • Prolactin: every 1–3 months initially • MRI: 6–12 months (macro) • Watch symptoms + tumor shrinkage
                • STOP TREATMENT?
                  After 2–3 years if: ○ Normal prolactin ○ Tumor resolved/minimal Recurrence: 20–50% → monitor
                  • COMPLICATIONS TO ADDRESS
                    Hypogonadism → estrogen/testosterone Osteoporosis risk → Ca + Vit D ± bisphosphonates
          • OBSERVE
            • FOLLOW-UP
              • Prolactin: every 1–3 months initially • MRI: 6–12 months (macro) • Watch symptoms + tumor shrinkage
              • STOP TREATMENT?
                After 2–3 years if: ○ Normal prolactin ○ Tumor resolved/minimal Recurrence: 20–50% → monitor
                • COMPLICATIONS TO ADDRESS
                  Hypogonadism → estrogen/testosterone Osteoporosis risk → Ca + Vit D ± bisphosphonates
  2. RULE OUT COMMON CAUSES (ALWAYS FIRST) “P-MHTS”
    P — Pregnancy (β-hCG) M — Medications (antipsychotics, SSRIs, metoclopramide) H — Hypothyroidism (↑TSH → treat) T — Transient stress → repeat test S — Secretory macroprolactin (inactive → no treatment)
tosprivacy